Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Other Non-Current Assets (2016 - 2025)

Editas Medicine (EDIT) has disclosed Other Non-Current Assets for 11 consecutive years, with $3.0 million as the latest value for Q3 2025.

  • Quarterly Other Non-Current Assets fell 43.38% to $3.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Sep 2025, down 43.38% year-over-year, with the annual reading at $5.2 million for FY2024, 39.18% down from the prior year.
  • Other Non-Current Assets for Q3 2025 was $3.0 million at Editas Medicine, down from $4.2 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $9.5 million in Q1 2024, with the low at $3.0 million in Q3 2025.
  • Average Other Non-Current Assets over 5 years is $6.3 million, with a median of $6.8 million recorded in 2023.
  • The sharpest move saw Other Non-Current Assets skyrocketed 179.72% in 2021, then tumbled 55.75% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $6.8 million in 2021, then decreased by 22.87% to $5.3 million in 2022, then soared by 63.49% to $8.6 million in 2023, then tumbled by 39.18% to $5.2 million in 2024, then tumbled by 42.75% to $3.0 million in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $3.0 million, $4.2 million, and $4.2 million for Q3 2025, Q2 2025, and Q1 2025 respectively.